期刊文献+

血管活性肠肽在调节肠黏膜屏障功能中的作用 被引量:17

Effects of vasoactive intestinal peptide on the modulation of gut barrier function
下载PDF
导出
摘要 血管活性肠肽(VIP)是由28个氨基酸残基构成的脑肠肽。它既是一种胃肠激素,同时又是非肾上腺素能非胆碱能(NANC)神经递质,并参与调节肠黏膜的机械、化学、免疫屏障及肠道动力,能有效保护肠黏膜屏障功能。 Vasoactive intestinal peptide is a braingut peptide made of 28 amino- acid residues. It is not only a gut hormone, but also a nonadrenergic noncholinergic(NANC) neurotransmitter, participating in the modulation of gut mechanical,chemical, immune barriers and gut motility. It can effectively protect gut barrier function.
出处 《国际消化病杂志》 CAS 2008年第3期226-229,共4页 International Journal of Digestive Diseases
关键词 血管活性肠肽 肠屏障 脑肠肽 Vasoactive intestinal peptide Gut barrier Braingut peptide
  • 相关文献

参考文献26

  • 1Kamata K, Sakamoto A, Kasuya Y. Similarities between relaxations induced by vasoactive intestinal peptide and by stimulation of the non-adrenergic non cholinergie neurons in the rat stomach. Pharmacol, 1988, 338 : 401-406.
  • 2Said SI, Mutt V. Polypeptide with broad biological activity: Isolation from small intestine. Science, 1970, 169: 1217-1218.
  • 3Bellinger DL, Lorton D, Romano TD, et al. Neuropeptide innervation of lymphoid organs. Ann NY Acad Sci, 1990, 594:17-33.
  • 4Martinez C, Delgado M, Abad C, et al. Regulation of VIP production and secretion by murine lymphocytes. Neuroimmunol, 1999, 93: 126-138.
  • 5Baumgart DC, Dignass AU. Intestinal barrier function. Curr Opin Clin Nutr Metab Care, 2002, 5: 685-694.
  • 6Schmitz H, Barmeyer C, Fromm M, et al. Altered tight junetion structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterol, 1999, 116:301-309.
  • 7Scott KG, Meddings JB, Kirk DR, et al. Intestinal infection with Giardia spp reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology, 2002, 123: 1179-1190.
  • 8Yu D, Seitz PK, Selvanayagam P, et al. Effects of vasoactive intestinal peptide on adenosine 3', 5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line. Endocrinol, 1992, 131:1181-1193.
  • 9Banan A, Zhang Y, Losurdo J, et al. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth alpha in a human colonic cell live. Gut, 2000, 46: 830-837.
  • 10Zandomeneghi R, Montanari P, Serra L, et al. Role of vasoae rive intestinal peptide(VIP)and somatostatin on the secretion of epidermal growth factor(EGF) : studies on duodenal tissue cultures. Regul Pept, 1990, 29: 75-80.

同被引文献272

引证文献17

二级引证文献205

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部